Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer

Clinical trial NCT07379918 · RECRUITING

Trial details

NCT number: NCT07379918
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer (Early Breast Cancer)Breast Cancer Survivors Breast Cancer Prognostic Early Hormone Receptor-positive (HR-positive)HER2-negative Breast Cancer

Start date: 2026-06-28
Primary completion: 2031-06-28
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.